Inotersen Subcutaneous and Insulin Aspart Protamine Injection
Determining the interaction of Inotersen Subcutaneous and Insulin Aspart Protamine Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: inotersen
Brand name: Tegsedi
Synonyms: Inotersen
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Inotersen Subcutaneous-Insulin aspart, recombinant Subcutaneous
- Inotersen Subcutaneous-Insulin degludec
- Inotersen Subcutaneous-Insulin Degludec (U-100) Prefilled Pens
- Inotersen Subcutaneous-Insulin Degludec (U-100) Vials
- Inotersen Subcutaneous-Insulin Degludec (U-200) Prefilled Pens
- Inotersen Subcutaneous-Insulin degludec and liraglutide
- Insulin Aspart Protamine Injection-Inotuzumab ozogamicin
- Insulin Aspart Protamine Injection-Inotuzumab ozogamicin Intravenous
- Insulin Aspart Protamine Injection-Inova
- Insulin Aspart Protamine Injection-Inova 4/1 topical
- Insulin Aspart Protamine Injection-Inova 8/2 topical
- Insulin Aspart Protamine Injection-Inova ACT